Search research articles
Contact Us
Filters
Showing results (91-100 of 96) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 96 results.
Clinical Pharmacology and Therapeutics
|
February 16, 2017
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update
J A Johnson, K E Caudle, L Gong, et al.
Clinical Pharmacology and Therapeutics
|
May 15, 2015
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
J K Hicks, J R Bishop, K Sangkuhl, et al.
Clinical Pharmacology and Therapeutics
|
November 8, 2012
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis
E Danese, M Montagnana, J A Johnson, et al.
Clinical Pharmacology and Therapeutics
|
October 20, 2015
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting
L V Kalman, Jag Agúndez, M Lindqvist Appell, et al.
Clinical Pharmacology and Therapeutics
|
February 10, 2016
Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network
W S Bush, D R Crosslin, A Owusu-Obeng, et al.
Clinical Pharmacology and Therapeutics
|
June 25, 2014
Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems
L J Rasmussen-Torvik, S C Stallings, A S Gordon, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 96) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 96 results.
Clinical Pharmacology and Therapeutics
|
February 16, 2017
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update
J A Johnson, K E Caudle, L Gong, et al.
Clinical Pharmacology and Therapeutics
|
May 15, 2015
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
J K Hicks, J R Bishop, K Sangkuhl, et al.
Clinical Pharmacology and Therapeutics
|
November 8, 2012
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis
E Danese, M Montagnana, J A Johnson, et al.
Clinical Pharmacology and Therapeutics
|
October 20, 2015
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting
L V Kalman, Jag Agúndez, M Lindqvist Appell, et al.
Clinical Pharmacology and Therapeutics
|
February 10, 2016
Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network
W S Bush, D R Crosslin, A Owusu-Obeng, et al.
Clinical Pharmacology and Therapeutics
|
June 25, 2014
Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems
L J Rasmussen-Torvik, S C Stallings, A S Gordon, et al.
Page
of 10